Market revenue in 2023 | USD 85.0 million |
Market revenue in 2030 | USD 389.2 million |
Growth rate | 24.3% (CAGR from 2023 to 2030) |
Largest segment | Wearable |
Fastest growing segment | Mobile based Applications |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Wearable, Mobile based Applications, Sensors |
Key market players worldwide | Amgen Inc, Biogen Inc, Pfizer Inc, ActiGraph, AliveCor, Koneksa Health, Altoida, Empatica, VivoSense, Ixico, Neurotrack, Aural Analytics, Sonde Health, Clario, Imagene AI, Brainomix, Kinsa, Feel Therapeutics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital biomarkers market will help companies and investors design strategic landscapes.
Wearable was the largest segment with a revenue share of 35.76% in 2023. Horizon Databook has segmented the Japan digital biomarkers market based on wearable, mobile based applications, sensors covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan digital biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into Japan digital biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account